Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Alvarez

Showing results (141-150 of 247) with videos related to

Pageof 25
Sort By:
Behaviour Research and Therapy|January 10, 2012
Effects of the dialectical behavioral therapy-mindfulness module on attention in patients with borderline personality disorderJoaquim Soler, Ana Valdepérez, Albert Feliu-Soler, et al.
Journal of Natural Products|October 10, 2022
Semisynthesis and Evaluation of Anti-Inflammatory Activity of the Cassane-Type Diterpenoid Taepeenin F and of Some Synthetic IntermediatesHouda Zentar, Fatin Jannus, Pilar Gutierrez, et al.
The Journal of General Virology|November 22, 2005
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid proteinJaehwan You, Brian K Dove, Luis Enjuanes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2002
Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic studyEnrique Alvarez, Julio Bobes, Juan-Carlos Gómez, et al.
Chemical Communications (Cambridge, England)|March 14, 2009
A thermal 6pi electrocyclization strategy towards taiwaniaquinoids. First enantiospecific synthesis of (-)-taiwaniaquinone GEnrique Alvarez-Manzaneda, Rachid Chahboun, Eduardo Cabrera, et al.
Journal of Neurology|November 6, 2025
Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS studyLe H Hua, Brandon Brown, Elizabeth Camacho, et al.
Neurology|January 13, 2019
Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosisJustin M Honce, Kavita V Nair, Stefan Sillau, et al.
Frontiers in Public Health|July 26, 2021
Monitoring and Analysis of COVID-19 Pandemic: The Need for an Empirical ApproachMartí Català, Miquel Marchena, David Conesa, et al.
Organic & Biomolecular Chemistry|December 22, 2009
An enantiospecific route towards taiwaniaquinoids. First synthesis of (-)-taiwaniaquinone H and (-)-dichroanoneEnrique Alvarez-Manzaneda, Rachid Chahboun, Eduardo Cabrera, et al.
Clinical Immunology (Orlando, Fla.)|October 10, 2023
Plasma IgG aggregates as biomarkers for multiple sclerosisWenbo Zhou, Michael Graner, Cheryl Beseler, et al.
Pageof 25

Showing results (141-150 of 247) with videos related to

Sort By:
Pageof 25
Behaviour Research and Therapy|January 10, 2012
Effects of the dialectical behavioral therapy-mindfulness module on attention in patients with borderline personality disorderJoaquim Soler, Ana Valdepérez, Albert Feliu-Soler, et al.
Journal of Natural Products|October 10, 2022
Semisynthesis and Evaluation of Anti-Inflammatory Activity of the Cassane-Type Diterpenoid Taepeenin F and of Some Synthetic IntermediatesHouda Zentar, Fatin Jannus, Pilar Gutierrez, et al.
The Journal of General Virology|November 22, 2005
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid proteinJaehwan You, Brian K Dove, Luis Enjuanes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2002
Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic studyEnrique Alvarez, Julio Bobes, Juan-Carlos Gómez, et al.
Chemical Communications (Cambridge, England)|March 14, 2009
A thermal 6pi electrocyclization strategy towards taiwaniaquinoids. First enantiospecific synthesis of (-)-taiwaniaquinone GEnrique Alvarez-Manzaneda, Rachid Chahboun, Eduardo Cabrera, et al.
Journal of Neurology|November 6, 2025
Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS studyLe H Hua, Brandon Brown, Elizabeth Camacho, et al.
Neurology|January 13, 2019
Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosisJustin M Honce, Kavita V Nair, Stefan Sillau, et al.
Frontiers in Public Health|July 26, 2021
Monitoring and Analysis of COVID-19 Pandemic: The Need for an Empirical ApproachMartí Català, Miquel Marchena, David Conesa, et al.
Organic & Biomolecular Chemistry|December 22, 2009
An enantiospecific route towards taiwaniaquinoids. First synthesis of (-)-taiwaniaquinone H and (-)-dichroanoneEnrique Alvarez-Manzaneda, Rachid Chahboun, Eduardo Cabrera, et al.
Clinical Immunology (Orlando, Fla.)|October 10, 2023
Plasma IgG aggregates as biomarkers for multiple sclerosisWenbo Zhou, Michael Graner, Cheryl Beseler, et al.
Pageof 25